Can Adipose Tissue Browning Become a New Frontier in Cardiometabolic Prevention?
Atherosclerosis posted on LinkedIn:
”Can adipose tissue browning become a new frontier in cardiometabolic prevention?
Emerging research is uncovering how browning of white adipose tissue (AT) – the conversion to a more metabolically active, thermogenic phenotype – could improve both metabolic and cardiovascular health.
- Pro-inflammatory pathways (NLRP3, TLR4, NF-κB) inhibit browning
- Anti-inflammatory signals (IL-4, IL-13, M2 macrophages) promote it, enhancing insulin sensitivity and glucose tolerance
- Mitochondrial effectors – UCP-1 and PGC1-α – are key drivers of thermogenesis
- Experimental interventions (ASK-1 knockout, nitrate, melatonin) improved endothelial function, atherosclerosis, and liver steatosis
While evidence is still largely preclinical, these findings suggest that targeting adipose tissue inflammation and mitochondrial function could open new therapeutic avenues for atherosclerotic cardiovascular disease.
Could “browning” therapies become part of the next generation of cardiometabolic treatments?”
Read the full article here.
Title: Molecular mechanisms linking adipose tissue browning to reduced cardiovascular risk
Authors: Ana Checa-Rosa, Luis D’Marco
Stay updated with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia